Biomarkers in Relation to Cognitive Reserve in Patients with Mild Cognitive Impairment - Proof of Concept

被引:30
作者
Rolstad, S. [1 ]
Nordlund, A. [1 ]
Eckerstrom, C. [1 ]
Gustavsson, M. H. [1 ]
Zetterberg, H. [1 ]
Wallin, A. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, SE-43131 Molndal, Sweden
基金
英国医学研究理事会;
关键词
Mild cognitive impairment; Cognitive reserve; Education; Biomarkers; ALZHEIMERS-DISEASE; CSF BIOMARKERS; CEREBROSPINAL-FLUID; EDUCATION; ASSOCIATION; DECLINE; OCCUPATION; STABILITY; DEMENTIA; RATES;
D O I
10.1159/000203130
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The concept of the cognitive reserve (CR) posits that factors such as education enable compensation for the effect of brain pathology. Consequently, pathology should be more pronounced in individuals with higher CR before becoming clinically apparent. Biomarkers such as total tau (t-tau) and beta-amyloid 42 (A beta 42) may be surrogates for pathology in relation to CR in patients with neurodegenerative disease. Objective: To examine the applicability of biomarkers as surrogates for pathology in relation to the CR in patients with mild cognitive impairment (MCI) either converting to dementia or remaining stable at follow-up. Method: Comparisons of baseline t-tau, A beta 42, educational years and global cognition for MCI patients either converting to dementia (n = 57) or remaining stable (n = 91) were made. Patients converting to dementia were grouped on the basis of educational level and compared considering biomarkers and neuropsychological tests. Results: Stable MCI patients were better educated, performed better cognitively, had higher A beta 42 levels and lower levels of t-tau. Converting MCI patients with higher education had lower levels of A beta 42 and performed equally in neuropsychological tests compared to those with lower education. Conclusion: Our results suggest that highly educated MCI patients subsequently converting to dementia display more amyloid pathology. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:194 / 200
页数:7
相关论文
共 41 条
  • [1] Predictors of cognitive change in older persons: MacArthur studies of successful aging
    Albert, MS
    Savage, CR
    Blazer, D
    Jones, K
    Berkman, L
    Seeman, T
    Rowe, JW
    [J]. PSYCHOLOGY AND AGING, 1995, 10 (04) : 578 - 589
  • [2] Reading ability, education, and cognitive status assessment among older adults in Harlem, New York City
    Albert, SM
    Teresi, JA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (01) : 95 - 97
  • [3] Alexander GE, 1997, AM J PSYCHIAT, V154, P165
  • [4] The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study
    Amieva, H
    Jacqmin-Gadda, H
    Orgogozo, JM
    Le Carret, N
    Helmer, C
    Letenneur, L
    Barberger-Gateau, P
    Fabrigoule, C
    Dartigues, JF
    [J]. BRAIN, 2005, 128 : 1093 - 1101
  • [5] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
    Andreasen, N
    Hesse, C
    Davidsson, P
    Minthon, L
    Wallin, A
    Winblad, B
    Vanderstichele, H
    Vanmechelen, E
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (06) : 673 - 680
  • [6] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
    Andreasen, N
    Minthon, L
    Davidsson, P
    Vanmechelen, E
    Vanderstichele, H
    Winblad, B
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 373 - 379
  • [7] Aspects of β-amyloid as a biomarker for Alzheimer's disease
    Andreasson, Ulf
    Portelius, Erik
    Andersson, Malin E.
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. BIOMARKERS IN MEDICINE, 2007, 1 (01) : 59 - 78
  • [8] *ANN, 1996, NEUROLOGY, V47, P592
  • [9] Education modifies the association of amyloid but not tangles with cognitive function
    Bennett, DA
    Schneider, JA
    Wilson, RS
    Bienias, JL
    Arnold, SE
    [J]. NEUROLOGY, 2005, 65 (06) : 953 - 955
  • [10] tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease?
    Blennow, K
    Wallin, A
    Agren, H
    Spenger, C
    Siegfried, J
    Vanmechelen, E
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) : 231 - 245